A critical discovery in cancer research is occurring with the use of VHH fragments to reactivate damaged p53. This essential malignant protector protein is frequently inactivated in several kinds of malignancies, https://getsocialselling.com/story7487360/mini-antibodies-revive-tumor-suppressor-p53-the-new-pathway-for-malignant-therapy